| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |